Chromocell Therapeutics (CHRO): O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti
Geopolitik beqarorlik va komponentlar yetkazib berish zanjiridagi uzilishlar Chromocell Therapeutics (CHRO) uchun sezilarli xavflarni yuzaga keltirmoqda. PEG koeffitsiyenti ushbu tebranishlarni vizuallashtiradi, bunda 0.00 qiymati joriy ko'rsatkichni ifodalaydi. Opioid bo'lmagan analgetiklarning bozorga chiqarilishi barqarorlikni ta'minlaydi, biroq ion kanallari inhibitorlarining muvaffaqiyatiga kuchli bog'liqlik kompaniyaning rivojlanish portfelida ikkilik zaiflikni saqlab qoladi.
Chromocell Therapeutics (CHRO) kompaniyasining tahliliy kesimlari
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- balans kapitallashuvi ko'rsatkichlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Chromocell Therapeutics|CHRO - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati chromocell.com|CHRO - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Chromocell Therapeutics Corporation|CHRO - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzi Chromocell Therapeutics|Tezkor likvidlik chromocell.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
CHRO - Sof daromad|Kutilayotgan sof daromad Chromocell Therapeutics|CHRO - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati Chromocell|CHRO - PEG multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Chromocell Therapeutics Corporation|CHRO - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Chromocell Therapeutics|CHRO - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi chromocell.com|CHRO - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Chromocell Therapeutics
Kompaniyaning umumiy tahlili:CHRO - Chromocell Therapeutics Corp
Chromocell Therapeutics (CHRO) kompaniyasiga investitsiya qilishga bo'lgan qiziqish bozor qiymati va foyda dinamikasi o'rtasidagi nisbatning chuqur tahlilini talab qiladi, buni ushbu past baholangan o'sish ko'rsatkichi aniq aks ettiradi. Ushbu metrika bozor kapitalizatsiyasini daromad o'sish sur'atlari bilan solishtiradi, bu esa kelajakdagi kapital qiymatini oshirish drayverlari sifatida robotlashtirilgan skrining tizimlari va klinik ma'lumotlarni dasturiy qayta ishlashni joriy etish samaradorligini baholash imkonini beradi.
Chromocell Therapeutics raqobatchilari
BIIB (Biogen Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Neurocrine Biosciences Inc NBIX|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti RGC|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda acadia-pharm.com|Xenon (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Viking Therapeutics Inc|Narxning foydaga va o‘sish sur’atiga nisbati Supernus Pharma|O‘sish sur’atiga tuzatilgan narx-foyda Catalyst Corp CPRX|PEG multiplikatori DNLI|Narx-foyda va o‘sish multiplikatori harmonybiosciences.com HRMY|PEG multiplikatori BHVN (Biohaven)|Amylyx Pharmaceuticals Inc (AMLX) - O‘sish sur’atiga tuzatilgan narx-foyda|TRVI - Narxning foydaga va o‘sish sur’atiga nisbati|PRAX: Narxning foydaga va o‘sish sur’atiga nisbati|Anavex Life Sciences (AVXL) - Narxning foydaga va o‘sish sur’atiga nisbati|CBLL (ceribell.com) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori PRTA|ALEC: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori ANNX (Annexon Inc.)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati OMER|PEG multiplikatori NGNE (Neurogene Inc.)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACIU|Voyager Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Neumora|Scilex Holding Co. (SCLX) - Narxning foydaga va o‘sish sur’atiga nisbati|Tevogen Bio Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|ACOG (Alpha Cognition Inc) - PEG multiplikatori|PEG multiplikatori cogrx.com|Narxning foydaga va o‘sish sur’atiga nisbati Inhibikase Therapeutics, Inc. (IKT)|SAVA: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori ASRT (Assertio)|Coya Therapeutics Inc (COYA) - O‘sish sur’atiga tuzatilgan narx-foyda|VTGN: Narx-foyda va o‘sish multiplikatori|OVID - PEG multiplikatori|ABOS (Acumen Pharmaceuticals, Inc.) - Narx-foyda va o‘sish multiplikatori|CRVO: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ATHE (Alterity Therapeutics Ltd.) - PEG multiplikatori|Clene Nanomedicine (CLNN) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori PEPG|Narx-foyda va o‘sish multiplikatori jupiterneurosciences.com JUNS|Narxning foydaga va o‘sish sur’atiga nisbati Relmada Therapeutics, Inc. RLMD|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Annovis Bio Inc (ANVS)|Grace Tx - PEG multiplikatori|Firefly Neuro (AIFF) - Narx-foyda va o‘sish multiplikatori|KLTO: PEG multiplikatori|NeuroSense Therapeutics Ltd. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Reviva Pharmaceuticals Holdings, Inc.|MTVA: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati NeurAxis, Inc (NRXS)|HSDT - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Passage Bio PASG|NEUP: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Minerva Neurosciences, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Athira Pharma Inc|ADXN (Addex Therapeutics, Ltd.) - Narx-foyda va o‘sish multiplikatori|Alzamend Neuro (ALZN) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Cyclerion Therapeutics Inc.|PTIX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Pasithea Therapeutics (KTTA)|CRGT - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori ATXI (Avenue Therapeutics, Inc)|BCLI - Narx-foyda va o‘sish multiplikatori|Cara Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ELYM (Eliem Therapeutics)|intracellulartherapies.com (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|Longboard Pharmaceuticals Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Marinus|O‘sish sur’atiga tuzatilgan narx-foyda NKGen Biotech Corp NKGN|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharmaceuticals (NRBO)|Narx-foyda va o‘sish multiplikatori sagerx.com SAGE|Narxning foydaga va o‘sish sur’atiga nisbati Synaptogenix SNPX|Trevena Inc. (TRVN) - O‘sish sur’atiga tuzatilgan narx-foyda|Vigil Neuro - PEG multiplikatori|Anew Medical Inc. (WENA) - Narx-foyda va o‘sish multiplikatori|CERE: PEG multiplikatori
